Veriskin is a company headquartered in the United States.
Veriskin develops TruScore, a handheld, non-invasive device that uses AI technology to provide fast and accurate skin cancer screening for frontline healthcare providers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.